Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer

Molecular Therapy

Volumn 22, Issue 8, 2014, Pages 1460-1471

  Hamann, Martin V ^a,b   Stanke, Nicole ^a,b   Müllers, Erik ^a,b   Stirnnagel, Kristin ^a,b   Hütter, Sylvia ^a,b   Artegiani, Benedetta ^b   Bragado Alonso, Sara ^b   Calegari, Federico ^b   Lindemann, Dirk ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VIRUS VECTOR; RNA; RNA DIRECTED DNA POLYMERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; SIGNAL TRANSDUCTION; SPUMA VIRUS; TRANSGENE; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PARTICLE; ANIMAL; CYTOLOGY; FIBROBLAST; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; METABOLISM; SPUMAVIRUS; TUMOR CELL LINE; VIROLOGY;

HUMAN SPUMARETROVIRUS;

ANIMALS; CELL LINE, TUMOR; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; IN VITRO TECHNIQUES; MICE; RNA; RNA-DIRECTED DNA POLYMERASE; SPUMAVIRUS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84905448172     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.82     Document Type: Article

References (41)

1. Suerth, JD, Schambach, A and Baum, C (2012). Genetic modification of lymphocytes by retrovirus-based vectors. Curr Opin Immunol 24: 598-608.
2. Naldini, L (2011). Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 12: 301-315.
3. Cavazza, A, Moiani, A and Mavilio, F (2013). Mechanisms of retroviral integration and mutagenesis. Hum Gene Ther 24: 119-131.
4. Schott, JW, Galla, M, Godinho, T, Baum, C and Schambach, A (2011). Viral and non-viral approaches for transient delivery of mRNA and proteins. Curr Gene Ther 11: 382-398.
5. Banasik, MB and McCray, PB Jr (2010). Integrase-defective lentiviral vectors: progress and applications. Gene Ther 17: 150-157.
6. Johnson, SF and Telesnitsky, A (2010). Retroviral RNA dimerization and packaging: the what, how, when, where, and why. PLoS Pathog 6: e1001007.
7. Rein, A, Datta, SA, Jones, CP and Musier-Forsyth, K (2011). Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci 36: 373-380.
8. Rulli, SJ Jr, Hibbert, CS, Mirro, J, Pederson, T, Biswal, S and Rein, A (2007). Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol 81: 6623-6631.
9. Rethwilm, A and Lindemann, D (2013). Foamy viruses. In: Knipe, DM, Howley, PM (eds. ). Fields Virology, 6th edn. , vol. 2. Chapter 52. Lippincott Williams & Wikins, a Wolters Kluwer business: Philadelphia, PA, pp. 1613-1632
10. Verhoeyen, E (2012). Advances in foamy virus vector technology and disease correction could speed the path to clinical application. Mol Ther 20: 1105-1107.
11. Nasimuzzaman, M and Persons, DA (2012). Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol Ther 20: 1158-1166.
12. Plochmann, K, Horn, A, Gschmack, E, Armbruster, N, Krieg, J, Wiktorowicz, T et al. (2012). Heparan sulfate is an attachment factor for foamy virus entry. J Virol 86: 10028-10035.
13. Lehmann-Che, J, Renault, N, Giron, ML, Roingeard, P, Clave, E, Tobaly-Tapiero, J et al. (2007). Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog 3: e74.
14. Trobridge, GD, Horn, PA, Beard, BC and Kiem, HP (2012). Large animal models for foamy virus vector gene therapy. Viruses 4: 3572-3588.
15. Mullers, E (2013). The foamy virus Gag proteins: what makes them different? Viruses 5: 1023-1041.
16. Hutter, S, Mullers, E, Stanke, N, Reh, J and Lindemann, D (2013). Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. J Virol 87: 3163-3176.
17. Deyle, DR, Li, Y, Olson, EM and Russell, DW (2010). Nonintegrating foamy virus vectors. J Virol 84: 9341-9349.
18. Lindemann, D and Rethwilm, A (2011). Foamy virus biology and its application for vector development. Viruses 3: 561-585.
19. Srinivas, S, Watanabe, T, Lin, CS, William, CM, Tanabe, Y, Jessell, TM et al. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.
20. Artegiani, B, Lange, C and Calegari, F (2012). Expansion of embryonic and adult neural stem cells by in utero electroporation or viral stereotaxic injection. J Vis Exp 6: pii.
21. Artegiani, B, Lindemann, D and Calegari, F (2011). Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain. J Exp Med 208: 937-948.
22. Galla, M, Schambach, A, Falk, CS, Maetzig, T, Kuehle, J, Lange, K et al. (2011). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res 39: 7147-7160.
23. Galla, M, Will, E, Kraunus, J, Chen, L and Baum, C (2004). Retroviral pseudotransduction for targeted cell manipulation. Mol Cell 16: 309-315.
24. Bieniasz, PD, Weiss, RA and McClure, MO (1995). Cell cycle dependence of foamy retrovirus infection. J Virol 69: 7295-7299.
25. Mullers, E, Stirnnagel, K, Kaulfuss, S and Lindemann, D (2011). Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses. J Virol 85: 9276-9285.
26. DuBridge, RB, Tang, P, Hsia, HC, Leong, PM, Miller, JH and Calos, MP (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
27. Rasheed, S, Nelson-Rees, WA, Toth, EM, Arnstein, P and Gardner, MB (1974). Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33: 1027-1033.
28. Mullers, E, Uhlig, T, Stirnnagel, K, Fiebig, U, Zentgraf, H and Lindemann, D (2011). Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol 85: 1452-1463.
29. Stirnnagel, K, Luftenegger, D, Stange, A, Swiersy, A, Mullers, E, Reh, J et al. (2010). Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7: 45.
30. Anastassiadis, K, Fu, J, Patsch, C, Hu, S, Weidlich, S, Duerschke, K et al. (2009). Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech 2: 508-515.
31. Konvalinka, J, Lochelt, M, Zentgraf, H, Flugel, RM and Krausslich, HG (1995). Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol 69: 7264-7268.
32. Lindemann, D, Pietschmann, T, Picard-Maureau, M, Berg, A, Heinkelein, M, Thurow, J et al. (2001). A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 75: 5762-5771.
33. Moebes, A, Enssle, J, Bieniasz, PD, Heinkelein, M, Lindemann, D, Bock, M et al. (1997). Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 71: 7305-7311.
34. Enssle, J, Moebes, A, Heinkelein, M, Panhuysen, M, Mauer, B, Schweizer, M et al. (1999). An active foamy virus integrase is required for virus replication. J Gen Virol 80 (Pt 6): 1445-1452.
35. Stirnnagel, K, Schupp, D, Dupont, A, Kudryavtsev, V, Reh, J, Mullers, E et al. (2012). Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles. Retrovirology 9: 71.
36. Lindemann, D, Stirnnagel, K, Luftenegger, D (2013). Foamy viral envelope genes. In: European Patent Office, EP (ed. ). Bulletin 2013/33, pp. 55.
37. Mochizuki, H, Schwartz, JP, Tanaka, K, Brady, RO and Reiser, J (1998). High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72: 8873-8883.
38. Amer, DA, Kretzschmar, G, Muller, N, Stanke, N, Lindemann, D and Vollmer, G (2010). Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line. J Steroid Biochem Mol Biol 120: 208-217.
39. Soneoka, Y, Cannon, PM, Ramsdale, EE, Griffiths, JC, Romano, G, Kingsman, SM et al. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23: 628-633.
40. Ho, YP, Schnabel, V, Swiersy, A, Stirnnagel, K and Lindemann, D (2012). A smallmolecule- controlled system for efficient pseudotyping of prototype foamy virus vectors. Mol Ther 20: 1167-1176.
41. Mannigel, I, Stange, A, Zentgraf, H and Lindemann, D (2007). Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 81: 3317-3326.